Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 50Neoplasms 22Pancreatic Neoplasms 21Neoplasm Metastasis 12Lung Neoplasms 12Brain Neoplasms 9Squamous Cell Carcinoma of Head and Neck 8Head and Neck Neoplasms 7Breast Neoplasms 7Gliosarcoma 6Glioblastoma 6Salivary Gland Neoplasms 5Rectal Neoplasms 5Glioma 5Colorectal Neoplasms 5Colonic Neoplasms 5Astrocytoma 5Unspecified Adult Solid Tumor, Protocol Specific 4Solid Tumors 4Esophageal Neoplasms 4Tongue Neoplasms 3Prostatic Neoplasms 3Oligodendroglioma 3Lymphoma 3Gallbladder Neoplasms 3Central Nervous System Neoplasms 3Carcinoma, Hepatocellular 3Bile Duct Neoplasms 3Advanced Cancers 3Advanced Cancer 3

Interventions

navicixizumab 1Erlotinib Hydrochloride 1Azacitidine 1Antibodies, Bispecific 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Advanced Solid Tumor Malignancies × Erlotinib Hydrochloride × Clear all
NCT00996515 2013-05-01

A Phase 1 Protocol of 5-Azacytidine and Erlotinib in Advanced Solid Tumor Malignancies

New Mexico Cancer Research Alliance

Phase 1 Completed
30 enrolled
Other solid neoplasm

Advanced Solid Tumor Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡